Literature DB >> 23305593

Laparoscopic cholecystectomy in the cirrhotic patient: predictors of outcome.

Ralph C Quillin1, Justin M Burns, Jaime A Pineda, Dennis Hanseman, Steven M Rudich, Michael J Edwards, Amit D Tevar.   

Abstract

BACKGROUND: We sought to determine the outcome predictors of 94 cirrhotic patients undergoing laparoscopic cholecystectomy (LC).
METHODS: We performed a single-center, retrospective review of cirrhotic patients undergoing LC for symptomatic gallbladder disease. Statistical analysis was completed using the Chi-square, Wilcoxon rank-sum, and Student t tests as appropriate.
RESULTS: Ninety-four procedures were completed. The median Child-Turcotte-Pugh (CTP) score was 6 (range, 5-12), and the average Model for End-Stage Liver Disease (MELD) score was 11 ± 5. Hepatitis C was the most common etiology of liver disease (50%) followed by Laennec's cirrhosis (22%). The average length of stay was 2.6 ± 4.3 days; 21% were outpatient procedures. The conversion rate was 11%. Conversion risk factors were decreased serum albumin, increased MELD score, and blood loss. Morbidity occurred in 32 patients. Predictors of morbidity were decreases in serum albumin, increases in International Normalized Ratio (INR) and CTP score, and the number of intraoperative red blood cell transfusions. Mortality occurred in 4 patients. Increased INR, CTP score, CTP class, the number of intraoperative blood and platelet transfusions were predictors of mortality.
CONCLUSION: LC can be safely performed in cirrhotic patients with appropriate patient selection. Liver synthetic function, operative blood loss, transfusion requirement, CTP, and MELD scores may be used to predict outcomes in these patients.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23305593     DOI: 10.1016/j.surg.2012.11.012

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy.

Authors:  Scott C Dolejs; Joal D Beane; Joshua K Kays; Eugene P Ceppa; Ben L Zarzaur
Journal:  Surg Endosc       Date:  2017-05-10       Impact factor: 4.584

Review 2.  Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Authors:  Bipadabhanjan Mallick; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

3.  Consecutive laparoscopic gallbladder and spleen resections in cirrhotic patients.

Authors:  Ming-Jun Wang; Jun-Li Li; Jin Zhou; Zhong Wu; Bing Peng
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 4.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Cholecystectomy in Patients with Liver Cirrhosis.

Authors:  Jonas Strömberg; Folke Hammarqvist; Omid Sadr-Azodi; Gabriel Sandblom
Journal:  Gastroenterol Res Pract       Date:  2015-12-14       Impact factor: 2.260

Review 6.  Gallstones in Patients with Chronic Liver Diseases.

Authors:  Xu Li; Xiaolin Guo; Huifan Ji; Ge Yu; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-01-31       Impact factor: 3.411

7.  Predictive Factors for Long Operative Duration in Patients Undergoing Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Combined Choledochocystolithiasis.

Authors:  Ryukyung Lee; Heontak Ha; Young Seok Han; Min Kyu Jung; Jae Min Chun
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2017-12       Impact factor: 1.719

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.